This page is the continuation of references in support of Section 8B
REFERENCES
Calman L, Beaver K, Hind D, et al. (2011). Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis. J Thorac Oncol 6(12), 1993. (Retrieved 26th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0041427/
Früh M, De Ruysscher D, Popat S, Crino J, Peteres S, Felip E. (2013). Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines. Ann Oncol 2013; 24 (Suppl 6): vi99-vi105. (Retrieved Feb 26th 2015): http://www.esmo.org/Guidelines/Lung-Cancer/Small-Cell-Lung-Cancer
Giaccone G, Ferrati P, Donadio M, Testore F, Calciati A. (1987) Reinduction chemotherapy in small cell lung cancer. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1697-9. (Retrieved 4th May 2015): http://www.ncbi.nlm.nih.gov/pubmed/2828074
Greco FA, Richardson RL, Snell JD, Stroup SL, Oldham RK. (1979) Small Cell Lung Cancer: Complete remission and improved survival. American Journal of Medicine:Volume 66, Issue 4:625–630. (Retrieved 4th May 2015): http://www.amjmed.com/article/0002-9343(79)91173-2/abstract
Jänne PA, Freidlin B, Saxman S, et al. (2002).Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America. Cancer 95(7), 1528. (Retrieved 26th Feb 2015): http://onlinelibrary.wiley.com/doi/10.1002/cncr.10841/full
Lebeau B, Chastang C, Brechot JM , Capron F, Dautzenberg B. et al. (1994) Subcutaneous heparin treatment increases survival in small cell lung cancer. Oncology & Radiology: Vol 74, Issue 1:38–45. (Retrieved 4th May 2015): http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(19940701)74:1%3C38::AID-CNCR2820740108%3E3.0.CO;2-E/abstract
Micke P, Faldum A, Metz T, et al. (2002). Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer – what limits limited disease? Lung Cancer 37, 271–276. (Retrieved 26th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/12234695
